The impact of chronic stress on the rat brain lipidome

Molecular Psychiatry

Volumn 21, Issue 1, 2016, Pages 80-88

  Oliveira, T G ^a,b   Chan, R B ^c   Bravo, F V ^a,b   Miranda, A ^a,b   Silva, R R ^a,b   Zhou, B ^c   Marques, F ^a,b   Pinto, V ^a,b   Cerqueira, J J ^a,b   Di Paolo, G ^c   Sousa, N ^a,b  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC SPHINGOMYELINASE; CERAMIDE; CORTICOSTERONE; DIACYLGLYCEROL; DIHYDROSPHINGOMYELIN; ETHER PHOSPHATIDYLCHOLINE; FATTY ACID; LACTOSYLCERAMIDE; LIPIDOME; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHATIDYLETHANOLAMINE; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; HYDROCORTISONE; LIPID;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CHRONIC UNPREDICTABLE STRESS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; HIPPOCAMPUS; LIPID BRAIN LEVEL; LIPID COMPOSITION; LIPIDOMICS; LONG TERM EXPOSURE; MASS SPECTROMETRY; NONHUMAN; PHOSPHOLIPID METABOLISM; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SPHINGOLIPID METABOLISM; ANIMAL; BLOOD; BRAIN; CHRONIC DISEASE; DISEASE MODEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MENTAL STRESS; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; UNCERTAINTY; WISTAR RAT;

ANIMALS; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HYDROCORTISONE; LIPIDS; MALE; MASS SPECTROMETRY; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; STRESS, PSYCHOLOGICAL; UNCERTAINTY;

EID: 84951906991     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2015.14     Document Type: Article

References (54)

1. Lupien SJ, McEwen BS, Gunnar MR, Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 2009; 10: 434-445.
2. Sousa N, Almeida OF. Disconnection and reconnection: the morphological basis of (mal)adaptation to stress. Trends Neurosci 2012; 35: 742-751.
3. Cerqueira JJ, Mailliet F, Almeida OF, Jay TM, Sousa N. The prefrontal cortex as a key target of the maladaptive response to stress. J Neurosci 2007; 27: 2781-2787.
4. Pinto V, Costa JC, Morgado P, Mota C, Miranda A, Bravo FV et al. Differential impact of chronic stress along the hippocampal dorsal-ventral axis. Brain Struct Func 2014. (e-pub ahead of print), 6 February 2014.
5. Dias-Ferreira E, Sousa JC, Melo I, Morgado P, Mesquita AR, Cerqueira JJ et al. Chronic stress causes frontostriatal reorganization and affects decision-making. Science 2009; 325: 621-625.
6. Roozendaal B, McEwen BS, Chattarji S. Stress memory and the amygdala. Nat Rev Neurosci 2009; 10: 423-433.
7. Catania C, Sotiropoulos I, Silva R, Onofri C, Breen KC, Sousa N et al. The amyloidogenic potential and behavioral correlates of stress. Mol Psychiatry 2009; 14: 95-105.
8. Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, Palha JA et al. The moodimproving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 2009; 148: 764-773, 739.
9. Sousa N, Almeida OFX. Disconnection and reconnection: the morphological basis of (mal) adaptation to stress. Trends Neurosci 2012; 35: 742-751.
10. Sousa N, Cerqueira JJ, Almeida OFX. Corticosteroid receptors and neuroplasticity. Brain Res Rev 2008; 57: 561-570.
11. Sousa N, Lukoyanov NV, Madeira MD, Almeida OFX, Paula-Barbosa MM. Reorganization of the morphology of hippocampal neurites and synapses after stressinduced damage correlates with behavioral improvement. Neuroscience 2000; 97: 253-266.
12. Sousa N, Almeida OFX. Corticosteroids: sculptors of the hippocampal formation. Rev Neurosci 2002; 13: 59-84.
13. Malcher-Lopes R, Franco A, Tasker JG. Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: a non-genomic antiinflammatory switch. Eur J Pharmacol 2008; 583: 322-339.
14. Patel S, Kingsley PJ, Mackie K, Marnett LJ, Winder DG. Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. Neuropsychopharmacology 2009; 34: 2699-2709.
15. Gulbins E, Palmada M, Reichel M, Luth A, Bohmer C, Amato D et al. Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs. Nat Med 2013; 19: 934-938.
16. Bessa JM, Mesquita AR, Oliveira M, Pego JM, Cerqueira JJ, Palha JA et al. A transdimensional approach to the behavioral aspects of depression. Front Behav Neurosci 2009; 3: 1.
17. Chan RB, Oliveira TG, Cortes EP, Honig LS, Duff KE, Small SA et al. Comparative lipidomic analysis of mouse and human brain with alzheimer disease. J Biol Chem 2012; 287: 2678-2688.
18. Dumont M, Stack C, Elipenahli C, Jainuddin S, Gerges M, Starkova N et al. Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice. Hum Mol Genet 2012; 21: 5091-5105.
19. Wenk MR. Lipidomics: new tools and applications. Cell 2010; 143: 888-895.
20. Carta M, Lanore F, Rebola N, Szabo Z, Da Silva SV, Lourenco J et al. Membrane lipids tune synaptic transmission by direct modulation of presynaptic potassium channels. Neuron 2014; 81: 787-799.
21. Lisowski P, Wieczorek M, Goscik J, Juszczak GR, Stankiewicz AM, Zwierzchowski L et al. Effects of Chronic Stress on Prefrontal Cortex Transcriptome in Mice Displaying Different Genetic Backgrounds. J Mol Neurosci 2013; 50: 33-57.
22. Gregg LC, Jung KM, Spradley JM, Nyilas R, Suplita RL 2nd, Zimmer A et al. Activation of type 5 metabotropic glutamate receptors and diacylglycerol lipasealpha initiates 2- arachidonoylglycerol formation and endocannabinoid-mediated analgesia. J Neurosci 2012; 32: 9457-9468.
23. Faria R, Santana MM, Aveleira CA, Simoes C, Maciel E, Melo T et al. Alterations in phospholipidomic profile in the brain of mouse model of depression induced by chronic unpredictable stress. Neuroscience 2014; 273: 1-11.
24. Hill MN, Patel S, Carrier EJ, Rademacher DJ, Ormerod BK, Hillard CJ et al. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology 2005; 30: 508-515.
25. Hillard CJ. Stress regulates endocannabinoid-CB1 receptor signaling. Semin Immunol 2014; 26: 380-388.
26. Lee LH, Shui G, Farooqui AA, Wenk MR, Tan CH, Ong WY. Lipidomic analyses of the mouse brain after antidepressant treatment: evidence for endogenous release of long- chain fatty acids? Int J Neuropsychopharmacol 2009; 12: 953-964.
27. Gault CR, Obeid LM, Hannun YA. An overview of sphingolipid metabolism: from synthesis to breakdown. Adv Exp Med and Biol 2010; 688: 1-23.
28. Kornhuber J, Muller CP, Becker KA, Reichel M, Gulbins E. The ceramide system as a novel antidepressant target. Trends Pharmacol Sci 2014; 35: 293-304.
29. Simons K, Gerl MJ. Revitalizing membrane rafts: new tools and insights. Nat Rev Mol Cell Biol 2010; 11: 688-699.
30. Dennis EA, Cao J, Hsu YH, Magrioti V, Kokotos G. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev 2011; 111: 6130-6185.
31. Lee LH, Tan CH, Shui G, Wenk MR, Ong WY. Role of prefrontal cortical calcium independent phospholipase A(2) in antidepressant-like effect of maprotiline. Int J Neuropsychopharmacol 2012; 15: 1087-1098.
32. Sundaram JR, Chan ES, Poore CP, Pareek TK, Cheong WF, Shui G et al. Cdk5/p25- induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration. J Neurosci 2012; 32: 1020-1034.
33. Green P, Gispan-Herman I, Yadid G. Increased arachidonic acid concentration in the brain of Flinders Sensitive Line rats, an animal model of depression. J Lipid Res 2005; 46: 1093-1096.
34. Green P, Anyakoha N, Yadid G, Gispan-Herman I, Nicolaou A. Arachidonic acidcontaining phosphatidylcholine species are increased in selected brain regions of a depressive animal model: implications for pathophysiology. Prostaglandins Leukot Essent Fatty Acids 2009; 80: 213-220.
35. Lamaziere A, Richard D, Barbe U, Kefi K, Bausero P, Wolf C et al. Differential distribution of DHA-phospholipids in rat brain after feeding: A lipidomic approach. Prostaglandins Leukot Essent Fatty Acids 2011; 84: 7-11.
36. Little SJ, Lynch MA, Manku M, Nicolaou A. Docosahexaenoic acid-induced changes in phospholipids in cortex of young and aged rats: a lipidomic analysis. Prostaglandins Leukot Essent Fatty Acids 2007; 77: 155-162.
37. Rao JS, Ertley RN, DeMar JC Jr., Rapoport SI, Bazinet RP, Lee HJ. Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex. Mol Psychiatry 2007; 12: 151-157.
38. 2+. Br J Pharmacol 2003; 139: 1014-1022.
39. Tiemeier H, van Tuijl HR, Hofman A, Kiliaan AJ, Breteler MM. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am J Clin Nutr 2003; 78: 40-46.
40. Ricart-Jane D, Rodriguez-Sureda V, Benavides A, Peinado-Onsurbe J, Lopez-Tejero MD, Llobera M. Immobilization stress alters intermediate metabolism and circulating lipoproteins in the rat. Metabolism 2002; 51: 925-931.
41. Chuang JC, Cui H, Mason BL, Mahgoub M, Bookout AL, Yu HG et al. Chronic socialdefeat stress disrupts regulation of lipid synthesis. J Lipid Res 2010; 51: 1344-1353.
42. Giovacchini G, Chang MC, Channing MA, Toczek M, Mason A, Bokde AL et al. Brain incorporation of [11C]arachidonic acid in young healthy humans measured with positron emission tomography. J Cereb Blood Flow Metab 2002; 22: 1453-1462.
43. Riederer M, Ojala PJ, Hrzenjak A, Graier WF, Malli R, Tritscher M et al. Acyl chaindependent effect of lysophosphatidylcholine on endothelial prostacyclin production. J Lipid Res 2010; 51: 2957-2966.
44. Kim WJ, Lee MJ, Park MA, Jung JS, Uhlinger DJ, Kwak JY. Dexamethasone enhances phospholipase D activity in M-1 cells. Exp Molecular Med 2000; 32: 170-177.
45. 2+ conductances: relevance to brain aging. Proc Natl Acad Sci U S A 1992; 89: 8527-8531.
46. Kim JH, Lee BD, Kim Y, Lee SD, Suh PG, Ryu SH. Cytosolic phospholipase A2-mediated regulation of phospholipase D2 in leukocyte cell lines. J Immunol 1999; 163: 5462-5470.
47. Oliveira TG, Di Paolo G. Phospholipase D in brain function and Alzheimer's disease. Biochim Biophys Acta 2010; 1801: 799-805.
48. Oliveira TG, Chan RB, Tian H, Laredo M, Shui G, Staniszewski A et al. Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits. J Neurosci 2010; 30: 16419-16428.
49. Feng PF, Huang CF. Phospholipase D-mTOR signaling is compromised in a rat model of depression. J Psychiatr Res 2013; 47: 579-585.
50. Song C, Zhang XY, Manku M. Increased phospholipase a2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment. J Neurosci 2009; 29: 14-22.
51. Tatebayashi Y, Nihonmatsu-Kikuchi N, Hayashi Y, Yu X, Soma M, Ikeda K. Abnormal fatty acid composition in the frontopolar cortex of patients with affective disorders. Transl Psychiatry 2012; 2: e204.
52. Schwarz E, Prabakaran S, Whitfield P, Major H, Leweke FM, Koethe D et al. High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides. J Proteome Res 2008; 7: 4266-4277.
53. Taha AY, Cheon Y, Ma K, Rapoport SI, Rao JS. Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients. J Psychiatr Res 2013; 47: 636-643.
54. Rao JS, Kim HW, Harry GJ, Rapoport SI, Reese EA. Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients. Schizophr Res 2013; 147: 24-31.